These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6271785)
1. Preparation and characterization of a probe for the cholecystokinin octapeptide receptor, N alpha (125I-desaminotyrosyl)CCK-8, and its interactions with pancreatic acini. Miller LJ; Rosenzweig SA; Jamieson JD J Biol Chem; 1981 Dec; 256(23):12417-23. PubMed ID: 6271785 [No Abstract] [Full Text] [Related]
2. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Jensen RT Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257 [TBL] [Abstract][Full Text] [Related]
3. Receptor binding of cholecystokinin analogues in isolated rat pancreatic acini. Doi R; Hosotani R; Inoue K; Fujii N; Yajima H; Rayford PL; Tobe T Biochem Biophys Res Commun; 1990 Jan; 166(1):286-92. PubMed ID: 2302208 [TBL] [Abstract][Full Text] [Related]
4. Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586 [TBL] [Abstract][Full Text] [Related]
5. Derivatives of CCK-(26-32) as cholecystokinin receptor antagonists in guinea pig pancreatic acini. Gardner JD; Knight M; Sutliff VE; Tamminga CA; Jensen RT Am J Physiol; 1984 Mar; 246(3 Pt 1):G292-5. PubMed ID: 6199984 [TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas. Povoski SP; Zhou W; Longnecker DS; Bell RH Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527 [TBL] [Abstract][Full Text] [Related]
7. Two functionally distinct cholecystokinin receptors show different modes of action on Ca2+ mobilization and phospholipid hydrolysis in isolated rat pancreatic acini. Studies using a new cholecystokinin analog, JMV-180. Matozaki T; Göke B; Tsunoda Y; Rodriguez M; Martinez J; Williams JA J Biol Chem; 1990 Apr; 265(11):6247-54. PubMed ID: 1690723 [TBL] [Abstract][Full Text] [Related]
8. Modulation of cholecystokinin activity by albumin. Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774 [TBL] [Abstract][Full Text] [Related]
9. Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini. Sankaran H; Goldfine ID; Deveney CW; Wong KY; Williams JA J Biol Chem; 1980 Mar; 255(5):1849-53. PubMed ID: 6243650 [TBL] [Abstract][Full Text] [Related]
10. Affinity labeling of a novel cholecystokinin-binding protein in rat pancreatic plasmalemma using new short probes for the receptor. Pearson RK; Miller LJ J Biol Chem; 1987 Jan; 262(2):869-76. PubMed ID: 3805011 [TBL] [Abstract][Full Text] [Related]
12. 125I-(Thr34, Nle37)- CCK31-39 a non oxidizable tracer for the characterization of CCK receptor on pancreatic acini and radio-immunoassay of C-terminal CCK peptides. Fourmy D; Pradayrol L; Vaysse N; Susini C; Ribet A J Immunoassay; 1984; 5(1-2):99-120. PubMed ID: 6201510 [TBL] [Abstract][Full Text] [Related]
14. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors. Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851 [TBL] [Abstract][Full Text] [Related]
15. Characterization of cholecystokinin receptors and messenger RNA expression in rat pancreas: evidence for expression of cholecystokinin-A receptors but not cholecystokinin-B (gastrin) receptors. Zhou W; Povoski SP; Bell RH J Surg Res; 1995 Mar; 58(3):281-9. PubMed ID: 7533864 [TBL] [Abstract][Full Text] [Related]
16. Characterization of central cholecystokinin receptors using a radioiodinated octapeptide probe. Wennogle LP; Steel DJ; Petrack B Life Sci; 1985 Apr; 36(15):1485-92. PubMed ID: 2984502 [TBL] [Abstract][Full Text] [Related]
17. Synthesis of cyclic analogues of cholecystokinin highly selective for central receptors. Rodriguez M; Amblard M; Galas MC; Lignon MF; Aumelas A; Martinez J Int J Pept Protein Res; 1990 May; 35(5):441-51. PubMed ID: 2376470 [TBL] [Abstract][Full Text] [Related]
18. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity. Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713 [TBL] [Abstract][Full Text] [Related]
19. Cholecystokinin-27-32-amide. A member of a new class of cholecystokinin receptor antagonists. Spanarkel M; Martinez J; Briet C; Jensen RT; Gardner JD J Biol Chem; 1983 Jun; 258(11):6746-9. PubMed ID: 6304053 [TBL] [Abstract][Full Text] [Related]
20. Suppression of Ca2+ oscillations induced by cholecystokinin (CCK) and its analog OPE in rat pancreatic acinar cells by low-level protein kinase C activation without transition of the CCK receptor from a high- to low-affinity state. Gaisano HY; Miller LJ; Foskett JK Pflugers Arch; 1994 Jul; 427(5-6):455-62. PubMed ID: 7971144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]